Patents Assigned to UNIVERSITY OF THE WITWATERSRAND
-
Patent number: 8541226Abstract: This invention relates to a bioreactor for producing high rates of hydrogen from plant biomass. It also relates to the rapid screening, selection and isolation of biofilm forming mesophilic and/or thermophilic bacteria or bacteria consortia that generate high levels of hydrogen from plant biomass or from soluble hydrolysates derived from the hydrolysis of cellulosic materials including hemicellulose. The reactor comprises a primary reactor vessel having a bed of hydrogen producing bacteria towards its base located within a secondary reactor vessel which functions as a hydrogen gas collector and as a clarifier and separator. The plant biomass may be one or a mixture of insoluble cellulosic material and a hydrolysate derived from hydrolysis of cellulosic material. In one embodiment the bed of the primary reactor vessel is fluidised by recycling hydrogen gas saturated plant biomass effluent from the secondary reactor vessel to the primary reactor vessel.Type: GrantFiled: September 9, 2008Date of Patent: September 24, 2013Assignee: University of the Witwatersrand, JohannesburgInventor: Vincent Myles Gray
-
Publication number: 20130216630Abstract: This invention relates to biomaterials, said biomaterials for use in methods to control and/or induce bone growth. Particularly, the invention relates to macroporous calcium phosphate biomaterials pre-loaded with certain amounts of osteoclastic activity inhibitors for use in methods to control and/or induce bone growth in primates.Type: ApplicationFiled: March 18, 2013Publication date: August 22, 2013Applicants: UNIVERSITY OF WITWATERSRAND, JOHANNESBURG, MEDICAL RESEARCH COUNCIL OF SOUTH AFRICAInventors: Medical Research Council of South Africa, University of Witwatersrand, Johannesburg
-
Publication number: 20130184421Abstract: The field of this invention relates to supramolecular functional materials, particularly to coordination networks, more particularly to coordination polymers, more particularly to metal based one-dimensional coordination polymers. The metal based one-dimensional coordination polymers comprises a repeat unit [L1-M-L2]n where L1 and L2 are one of a plurality of carboxylate ligands and L1 can be the same as L2, M is a metal, particularly a transition metal, and n is an integer from 1 to infinity. The metal based one-dimensional coordination polymers display one or more physico-chemical properties giving at least one functionality to the supramolecular material.Type: ApplicationFiled: March 7, 2013Publication date: July 18, 2013Applicant: UNIVERSITY OF THE WITWATERSRANDInventor: University of the Witwatersrand
-
Patent number: 8481740Abstract: This invention relates to the manufacture of novel chemical compounds which have biological activity, particularly to novel chemical compounds that are cytotoxic against colon cancer cells and colon cancer cell lines. The manufacturing of said chemical compounds displaying anti-cancer properties employs the use of multi-component chemical reactions. The object of this invention is to manufacture and isolate analogues of imidazo[1,2-a]pyridine, namely compounds of Formula 1, which are cytotoxic against colon cancer cells, while concomitantly being relatively inactive against white blood cells. wherein, R is bromo, methyl, phenyl, nitro, hydrogen or an amide functional group; R1 is benzyl, 2,6-dimethylphenyl or cyclohexyl; and R2 is methoxy, benzyloxy or hydroxy.Type: GrantFiled: April 1, 2010Date of Patent: July 9, 2013Assignee: University of the Witwatersrand, JohannesburgInventors: Nurit Esperance Farkas (Nee Dahan), Hajierah Davids, Candice Langley, Charles Bernard De Koning
-
Patent number: 8455602Abstract: The field of this invention relates to supramolecular functional materials, particularly to coordination networks, more particularly to coordination polymers, more particularly to metal based one-dimensional coordination polymers. The metal based one-dimensional coordination polymers comprises a repeat unit [L1-M-L2]n where L1 and L2 are one of a plurality of carboxylate ligands and L1 can be the same as L2, M is a metal, particularly a transition metal, and n is an integer from 1 to infinity. The metal based one-dimensional coordination polymers display one or more physico-chemical properties giving at least one functionality to the supramolecular material.Type: GrantFiled: August 24, 2010Date of Patent: June 4, 2013Assignee: University of the Witwatersrand, JohannesburgInventor: Manuel Antonio Fernandes
-
Publication number: 20130052645Abstract: This invention describes a method for identifying bacteria. In particular, this invention relates to a method for identifying and quantifying mycobacteria from a sputum sample taken from a subject using flow cytometry. Further described is the use of flow cytometry to identify and quantify Mycobacterium tuberculosis from sputum-derived samples. Once identified and quantified, the samples are spotted onto filter cards for use in verification of an existing method of diagnosis, calibration of an existing method of diagnosis and/or the establishment of an external quality control system for use in conjunction with these methods of diagnosis. In one embodiment the method is used to diagnose tuberculosis (TB).Type: ApplicationFiled: May 6, 2011Publication date: February 28, 2013Applicant: University of the Witwatersrand, JohannesburgInventor: Lesley Erica Scott
-
Publication number: 20120277328Abstract: This invention relates to a process for the conversion of carbon containing feedstock to a liquid chemical product, particularly a liquid fuel product, wherein carbon dioxide emissions are minimized.Type: ApplicationFiled: October 28, 2010Publication date: November 1, 2012Applicant: UNIVERSITY OF THE WITWATERSRANDInventor: Shehzaad Kauchali
-
Patent number: 8293974Abstract: A DNA polynucleotide is described herein having a modified sequence of a target gene, wherein any one type of nucleotide in the target gene sequence has been chemically modified to another type of nucleotide; and a complementary sequence of the unmodified target gene; wherein either one of the modified sequence or the complementary sequence is in a reverse orientation to the other sequence; and wherein the RNA sequence transcribed from the DNA polynucleotide forms a duplex between the modified sequence and the complementary sequence so that a long double stranded RNA (IdsRNA) duplex forms between the modified and complementary sequences with base pair mismatches where the nucleotides have been modified, the IdsRNA duplex being capable of inhibiting expression of the target gene. RNA polynucleotides and IdsRNA duplexes transcribed by the DNA polynucleotide are also described, as is a method for producing the IdsRNA duplexes. These IdsRNA duplexes can be used in gene silencing.Type: GrantFiled: January 29, 2008Date of Patent: October 23, 2012Assignee: University of WitwatersrandInventors: Patrick Arbuthnot, Marc Saul Weinberg, Marie Emma Christine Rey, Johan Harmse, Sarah Helen Taylor
-
Publication number: 20120241675Abstract: A system for the production of synthesis gas and, for the production thereof, where the system is preferably a net carbon dioxide absorber. The invention covers both the methodology for the development of the process and the system for the implementation of the process, inclusive of the required utility systems.Type: ApplicationFiled: May 26, 2010Publication date: September 27, 2012Applicant: University of the Witwatersrand, JohannesburgInventors: James Alistair Fox, Diane Hildebrandt, David Glasser, Bilal Patel, Brendon Hausberger, Baraka Celestin Sempuga
-
Patent number: 8237124Abstract: This invention relates to a coded aperture mask for use in diagnostic nuclear medicine imaging. The coded aperture mask consists of a sheet of radiation opaque mask material having a series of apertures extending therethrough. The thickness of mask material has an attenuation percentage of less than 75% and, in a preferred embodiment, about equal to 29%. The coded aperture mask also, in a preferred embodiment, has a lead attenuation tube and has a projection of the smallest hole occupying the same area as a single pixel of a detector. The invention extends to a diagnostic nuclear medicine imaging system which uses a 16 bit gamma camera as a radiation detector.Type: GrantFiled: May 22, 2008Date of Patent: August 7, 2012Assignee: University of the Witwatersrand, JohannesburgInventors: Tshilidzi Marwala, David Milton Rubin, David Mark Starfield
-
Publication number: 20120106699Abstract: This invention relates to a method and an apparatus, primarily a radiation imaging apparatus and an array of coded aperture masks, for use in diagnostic nuclear medicine. The coded aperture masks are fitted with radiation attenuation tubes, each of which extends from each side of the mask in the direction of the mask apertures. The tubes are made from lead and have parallel sides. The masks are configured for gamma ray usage and are made from tungsten having a thickness of between 1 and 2 mm.Type: ApplicationFiled: December 8, 2010Publication date: May 3, 2012Applicant: UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURGInventors: David Mark STARFIELD, David Milton RUBIN, Tshilidzi MARWALA
-
Patent number: 8168684Abstract: This invention relates to a method of producing liquid hydrocarbons, preferably internal combustion engine fuels, using feedstocks of coal or methane. Depending on the nature of the feedstock it is subjected to a gasification and/or reforming process and/or water gas shift process which produces a syngas that is rich in carbon dioxide and hydrogen rather than carbon monoxide and hydrogen as in the conventional process. The carbon dioxide and hydrogen are combined in a Fischer Tropsch process to produce desired hydrocarbons and water. The energy requirements of the gasification/reforming process to produce a syngas that is rich in carbon dioxide and hydrogen is considerably less than the energy requirements for gasification/reforming process for producing the conventional carbon monoxide rich syngas. This reduction in energy consumption reduces considerably the quantities of carbon dioxide released into the atmosphere compared to conventional processes that are based on carbon monoxide rich syngas.Type: GrantFiled: April 24, 2007Date of Patent: May 1, 2012Assignee: University of the Witwatersrand, JohannesburgInventors: Diane Hildebrandt, David Glasser, Bilal Patel, Brendon Patrick Hausberger
-
Publication number: 20120088266Abstract: This invention relates to bioreactor processes, particularly bioreactor processes for the production of hydrogen gas from biomass, more particularly to bioreactor processes for the production of hydrogen gas employing a mixed anaerobic thermophilic bacterial consortium during the anaerobic fermentation of biomass.Type: ApplicationFiled: May 14, 2010Publication date: April 12, 2012Applicant: UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURGInventor: Vincent Myles Gray
-
Publication number: 20120064142Abstract: This invention relates to a polymeric pharmaceutical dosage form for the delivery, in use, of at least one pharmaceutical composition in a rate-modulated and site-specific manner. The dosage form comprises a biodegradable, polymeric, scaffold incorporating loaded with at least one active pharmaceutical ingredient (API). The polymer or polymers making up the scaffold degrade in a human or animal body in response to or in the absence of specific biological stimuli and, on degradation, release the API or APIs in an area where said stimuli are encountered. Preferably the polymeric scaffold is formed from poly (D1L-lactide) (PLA) and polymethacrylate (Eudragit S100/ES100) polymers.Type: ApplicationFiled: November 30, 2009Publication date: March 15, 2012Applicant: UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURGInventors: Viness Pillay, Yahya Essop Choonara, Bongani Sibeko, Sheri-Lee Harilall, Samatha Pillay, Girish Modi, Sunny Esayegbemu Iyuke, Dinesh Naidoo
-
Publication number: 20110307074Abstract: This invention relates to biomaterials, said biomaterials for use in methods to control and/or induce bone growth. Particularly, the invention relates to macroporous calcium phosphate biomaterials pre-loaded with certain amounts of osteoclastic activity inhibitors for use in methods to control and/or induce bone growth in primates.Type: ApplicationFiled: July 15, 2011Publication date: December 15, 2011Applicants: UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG, MEDICAL RESEARCH COUNCIL OF SOUTH AFRICAInventors: Ugo Ripamonti, Carlo Ferretti
-
Patent number: 8018705Abstract: A spark gap protection device is provided. The device comprises a plurality of spark gaps and a plurality of windings. Each spark gap is connected to at least one winding which is inductively coupled to an associated winding connected to another spark gap so that, in use, a surge current flowing across a spark gap and through a winding connected to the spark gap induces a voltage in the associated inductively coupled winding connected to another spark gap. This forces the other spark gap to trigger, thereby distributing the surge current between the spark gaps.Type: GrantFiled: May 21, 2010Date of Patent: September 13, 2011Assignee: University of WitwatersrandInventors: Aristidis Michalopoulos, Ian Robert Jandrell, John Michael Van Coller, Andreas Alan Beutel
-
Publication number: 20110212154Abstract: The invention relates to biodegradable and implantable devices for the in situ delivery of a pharmaceutical composition to a human or animal that comprise a generally discoid body, having at least one aperture through which the body is anchorable by suture, and that are formed from biodegradable polymeric compositions. The invention relates to methods of manufacturing devices for the in situ delivery of a pharmaceutical composition to a human or animal that comprise a generally discoid body, having at least one aperture through which the body is anchorable by suture, and that are formed from biodegradable polymeric compositions. The invention relates to a therapeutic method that comprises inserting a biodegradable and implantable device that comprises a generally discoid body, having at least one aperture through which the body is anchorable by suture, and that is formed from a biodegradable polymeric composition, into a body cavity of a human or animal.Type: ApplicationFiled: February 4, 2011Publication date: September 1, 2011Applicant: University of the WitwatersrandInventors: Yahya E. Choonara, Micheal P. Danckwerts, Viness Pillay
-
Publication number: 20110190881Abstract: This invention relates to a means for compensating for a whole or partial loss of speech. The means has a sensor unit in the form of a Logometrix pseudo palate and a palatometer which sense the position of a user's tongue while endeavouring to articulate words or sounds. The sensor unit is connected to a comparator which makes use of suitable artificial intelligence algorithms (such as Multi-Layer Perceptron Neural Networks and Hidden Markov Models) together with a library of stored words and sounds as well as tongue positions and signals related to jaw and lip movement as well as inhalation and exhalation to match words or sounds and transmit the matched words or sounds to a loudspeaker. Preferably the output of the loudspeaker will simulate the natural voice of the user.Type: ApplicationFiled: June 30, 2009Publication date: August 4, 2011Applicant: University of the Witwatersrand, JohannesburgInventors: Megan Jill Russell, David Milton Rubin, Brian Wigdorowitz, Tshilidzi Marwala
-
Publication number: 20110190616Abstract: This invention relates to a coded aperture mask for use in diagnostic nuclear medicine imaging. The coded aperture mask consists of a sheet of radiation opaque mask material having a series of apertures extending therethrough. The thickness of mask material has an attenuation percentage of less than 75% and, in a preferred embodiment, about equal to 29%. The coded aperture mask also, in a preferred embodiment, has a lead attenuation tube and has a projection of the smallest hole occupying the same area as a single pixel of a detector. The invention extends to a diagnostic nuclear medicine imaging system which uses a 16 bit gamma camera as a radiation detector.Type: ApplicationFiled: May 22, 2008Publication date: August 4, 2011Applicant: UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURGInventors: Tshilidizi Marwala, David Milton Rubin, David Mark Starfield
-
Patent number: 7915590Abstract: This invention relates to a method and an apparatus, primarily a radiation imaging apparatus and an array of coded aperture masks, for use in diagnostic nuclear medicine. The coded aperture masks are fitted with radiation attenuation tubes, each of which extends from each side of the mask in the direction of the mask apertures. The tubes are made from lead and have parallel sides. The masks are configured for gamma ray usage and are made from tungsten having a thickness of between 1 and 2 mm.Type: GrantFiled: November 2, 2006Date of Patent: March 29, 2011Assignee: University of the Witwatersrand, JohannesburgInventors: David Mark Starfield, David Milton Rubin, Tshilidzi Marwala